[Effectiveness of Ge-132 to relieve pain and smooth home care administration for the terminal cancer patient].

Measures to alleviate pain are the most important issue in care of the cancer patient. In the present study, we investigated whether the use of narcotics could be reduced in the use of Ge-132 (Repargermanium) when used alone or together with a narcotic as a means to facilitate pain management in home care. The patients have died at home over the past 2 years with various types of cancer under our hospital supervision. Five were cases of bone metastasis, 6 of ascites. All cases had been given Ge-132, 750 approximately 2,500 mg/day (mean 1,000 mg) either orally or by IV. For pain control the first choice was MS Contin, and when the need arose the route used was intravenous or by suppository. We investigated the rate of narcotic usage and the dosage of same. Narcotics were used in 7 of the 16 patients (44%) who died at home, and the daily dose was 20 approximately 240 mg (mean 60 mg). By using Ge-132 as a pain killer the rate of narcotics use and the dosage were decreased, resulting in less side effects from the narcotics. Thus, Ge-132 proved effective in relieving the pain of the terminal cancer patient receiving home care, and since it has no side effects it assures smooth home treatment.